Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils

Authors

R. K. Thimmulappa
R. J. Fuchs
D. Malhotra
C. Scollick
K. Traore
J. H. Bream
M. A. Trush
K. T. Liby
M. B. Sporn
T. W. Kensler
S. Biswal

Document Type

Article

Date of Publication

11-9-2007

Publication Title

Antioxidants & Redox Signaling

First Page

1963

Last Page

1970

Recommended Citation

Thimmulappa, R. K.; Fuchs, R. J.; Malhotra, D.; Scollick, C.; Traore, K.; Bream, J. H.; Trush, M. A.; Liby, K. T.; Sporn, M. B.; Kensler, T. W.; and Biswal, S., "Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils" (2007). Osteopathic Medicine, Jerry M. Wallace School of. 1660.
https://cufind.campbell.edu/medicine_school/1660